← Back to Search

A Study of MiRNA 371 in Patients with Germ Cell Tumors

Mount Vernon, IL
N/A
Waitlist Available
Led By Craig R Nichols
Research Sponsored by SWOG Cancer Research Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

See full description
Eligible Conditions
  • Seminoma
  • Malignant Neoplasm
  • Testicular cancer
  • Germ Cell Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To bank blood specimens of patients at low risk and moderate risk of relapse
To estimate positive predictive value of miRNA 371 in early stage testicular seminoma and nonseminoma patients

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (blood collection)Experimental Treatment2 Interventions
Patients undergo collection of blood every 3-6 months for up to 3 years.

Find a Location

Closest Location:Good Samaritan Regional Health Center· Mount Vernon, IL

Who is running the clinical trial?

SWOG Cancer Research NetworkLead Sponsor
402 Previous Clinical Trials
265,719 Total Patients Enrolled
Southwest Oncology GroupLead Sponsor
388 Previous Clinical Trials
259,055 Total Patients Enrolled
National Cancer Institute (NCI)NIH
14,050 Previous Clinical Trials
41,147,939 Total Patients Enrolled
8 Trials studying Seminoma
4,411 Patients Enrolled for Seminoma
Craig R NicholsPrincipal InvestigatorSWOG Cancer Research Network
~261 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top